|

Relugolix-Containing Product Clinical Trials

1 actively recruiting trial across 1 location

Also known as: MVT-601, MVT-601A, MYFEMBREE, RVT-601, T-1331285 +1 more

Top Sponsors

  • Sumitomo Pharma Switzerland GmbH1

Indications

  • Pregnancy, High Risk1
  • Pregnancy Complications1
  • Pregnancy Related1
  • Cancer1

Wilmington, North Carolina1 trial

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

PPD

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.